ask="6.80"
ask_size="200"
average_daily_volume="174560"
bid="N/A"
bid_size="N/A"
book_value="3.28"
change="+0.35"
change_from_200_day_moving_average="-4.32"
change_from_50_day_moving_average="0.19"
change_from_52_week_high="-12.00"
change_From_52_week_low="1.20"
change_in_percent="+6.54%"
close="5.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.54"
ebitda="-19.38M"
eps_estimate_current_year="-2.82"
eps_estimate_next_quarter="-0.94"
eps_estimate_next_year="-2.58"
ex_dividend_date="N/A"
float_shares="5820000"
high="5.75"
high_52_weeks="17.70"
last_trade_date="2/3/2017"
last_trade_price="5.70"
last_trade_size="510"
last_trade_time="4:00pm"
low="5.25"
low_52_weeks="4.50"
market_capitalization="44.56M"
moving_average_200_day="10.02"
moving_average_50_day="5.51"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.92"
open="5.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-43.09%"
percent_change_from_50_day_moving_average="+3.44%"
percent_change_from_52_week_high="-67.80%"
percent_change_from_52_week_low="+26.67%"
previous_close="5.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.63"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.40"
stock_exchange="NCM"
symbol="TRIL"
volume="148911"
weeks_range_52="4.50 - 17.70"
